ARCHIVES

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

This article is from The Cancer Letter archive.

Vol. 37 No. 43 | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

Lymphoblastoid If Test Shows Toxicity Not From Impurity, Investigator Says

August 8, 1980

ODACSupports Temodal For Treatment of Astrocytoma

January 22, 1999

Physicians Not Giving Enough Narcotics For Effective Pain Control, M.D. Anderson Specialist Tells Seminar

April 14, 1989

President Requests Extra $200 Million For NIH

March 7, 2014

New Phone Number For Customer Service For The Cancer Letter

February 6, 1998

NS Sponsors Workshop On Prevention For Three Minority Groups

July 1, 1988